Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: BigKNY3 who wrote (6185)	11/2/1998 12:04:00 AM
From: Brander	Respond to of 9523

BigK, <<PS Note: Due to major time obligations and apparent lack of interest in The Peabody Reports on the PFEr Boards>> I understand that time is a limited resource, and I can only imagine how much time you put into the Peabody Reports. I assure you, however, that to this investor, there is no lack of interest. To me, they are one of the most informative private reports I have run across on SI or any other public stock bulletin board. I would hate to see them end. Brad

To: BigKNY3 who wrote (6185)	11/2/1998 4:20:00 AM
From: WS_DE	Read Replies (1) \| Respond to of 9523

BigKNY3: <<PS Note: Due to major time obligations and apparent lack of interest in The Peabody Reports on the PFEr Boards, Mr. Peabody may be closing the show>> I am always VERY MUCH interested in your Peabody Report and in ALL your activities in this thread! Please DON'T stop it, Please DON'T stop it, Please DON'T stop it! It would be a big loss for this board, and I am absolutely sure that this is not only my opinion but the opinion of most of the people who come here. W_S (Germany/Europe)

To: BigKNY3 who wrote (6185)	11/2/1998 10:41:00 AM
From: Anthony Wong	Read Replies (1) \| Respond to of 9523

Pfizer to Produce Viagra in Southeastern England, Paper Says Bloomberg News November 2, 1998, 7:53 a.m. ET London, Nov. 2, (Bloomberg) -- Pfizer Inc., a U.S. pharmaceuticals company, plans to invest 5 million pounds ($8.34 million) to produce its Viagra impotence treatment in Sandwich, southeastern England, the Evening Standard reported, citing Ken Moran, chairman of Pfizer U.K. The company has pledged to double its investment in Britain to 250 million pounds next year and hopes sales of Viagra from the plant will reach 50 million pounds within five years. Pfizer's Viagra production plans, which are part of a program to create 1,700 jobs in southeast England, could help it win National Health Service funding for Viagra, the paper reported. Pfizer said last month that third-quarter sales of Viagra, which was approved by the European Union on Sept. 15, slowed to $141 million from $411 million in the second quarter, following the most successful ever U.S. intoduction of any drug in April. (Evening Standard 11/2 34) --Chris Collins in the London newsroom (44 171) 330 7699/sm